KCT0001431已完成未知
A Randomized, Open-label, Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation After Multiple Dosing Under Fasted Condition in Healthy Male Subjects
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 45(Year)（—）
- 性别
- Male
入选标准
- •20~45 aged healthy adult.
- •someone tho has at least 50kg body weight and ideal body weight ±20%
排除标准
- •someone has acute symptom at screening phase
- •someone has any disease or symptoms which is clinically significant
- •someone had been determined during healthy examination in screening period
- •AST or ALT > 1.5 times than normal
- •Total bilirubin > 1.5 times than normal
- •someone who has a history of allergy, anaphylaxis, drug abuse or misuse.
- •someone who had enrolled to other clinical trial within the last 60 days.
- •someone who had donated blood within the last 60 days.
- •someone who can't take a meal derived from this trial.
- •someone who has taken abnormal meals like which can affect to drug Absorbtion, Distribution, Metabolism, Excretion
- •someone who has taken other prescription medicine or oriental drugs within the last 14 days, Or over-the-counter drugs within the last 7 days
- •someone who has taken caffein continuously (coffee or green tea more than 5 cups per a day) or took caffein since 24hours before.
- •someone who has taken alcohol more than 30g/day or smoked more than 10 piece of tobacco/day.
- •someone who has galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
研究者
相似试验
已完成
不适用
A Crossover Clinical Trial to Compare The Pharmacokinetics of A GLA5PR GLARS-NF1 tablet 150mg and Immediate Release Formulation After Multiple Dosing under Fed Condition in Healthy Male SubjectsEndocrine, nutritional and metabolic diseaseKCT0001338GL PharmTech24
进行中（未招募）
4 期
Evaluation of the Implantation of an Anticoagulation Clinic in the Assistance of Chagas and Non-Chagas Patients at the Hospital of Clinics of the Universidade Federal de Minas Gerais - UFMGC03.752.300.900.200Heart DiseasesChagas DiseaseHemorrhageThrombosisD03.438.150.446.520.914C14.907.355C14.280.067.198C23.550.414RBR-88btzpniversidade Federal de Minas Gerais
进行中（未招募）
不适用
Antiproteinuric effect of three different types of diuretics in patients with chronic proteinuric nephrophaties.Chronic proteinuric nephropathiesEUCTR2011-001929-24-ESFundación para la Investigación Biomédica del Hospital 12 de Octubre
进行中（未招募）
不适用
Optimizing treatment of maldigestion in patients with chronic pancreatitisEUCTR2015-002570-20-ESDepartment of gastroenterology. University Hospital of Santiago
已完成
不适用
Clinical trial to investigate pharmacokinetics and drug interaction of Crestor and Glucodown OR SR in healthy volunteersEndocrine, nutritional and metabolic diseaseKCT0000349Yuhan36